Study: Nusinersen Improved Function in SMA Type 2 Patients

Distributor hopes to launch the treatment for SMA patients in the United States in coming months.

• By Laurie Watanabe
• Nov 29, 2016

Study: Ultrasound a Viable Risk Assessment Tool for Deep Tissue Injuries

More portable and less expensive than MRIs, ultrasound technology could be more convenient for clinicians to use.

• By Laurie Watanabe
• Oct 06, 2016

Study: Cell Therapy Could Treat SCI Side Effects

UCSF researchers transplanted human neurons into mice with spinal cord injuries.

• By Laurie Watanabe
• Oct 06, 2016

Researchers “Reverse” Protein Mutation Linked to ALS

By mutating the mutation, scientists stabilized a protein that had been harming neurons.

• By Laurie Watanabe
• Sep 23, 2016

Temporary Tattoos Could Help Treat MS

Targeted therapy strategy could reduce patients' exposure to side effects.

• By Laurie Watanabe
• Sep 23, 2016

Study: Common Disorders Frequently Misdiagnosed as MS

New research points out the challenge of correctly identifying multiple sclerosis.

• By Laurie Watanabe
• Sep 15, 2016

New Report Puts Global Power Wheelchair Market at $2.4 Billion in 2022

All types of power chairs are included in new study.

• By Laurie Watanabe
• Aug 24, 2016

Research: Dystonia Medication Can Work on Multiple Areas of the Brain

Drug commonly used to treat dystonia symptoms could also work on cervical dystonia.

• By Laurie Watanabe
• Jun 24, 2016

Study: Fatigue in MS Patients Linked to Poor Sleep Quality

People with multiple sclerosis could be helped by sleep assessments, research suggests.

• By Laurie Watanabe
• Jun 08, 2016

FDA Advisory Panel Declines to Support DMD Drug

Accelerated approval is in jeopardy for drug that addresses Duchenne muscular dystrophy's genetic cause.

• By Laurie Watanabe
• May 13, 2016

Walk-DMC Assessment Seeks to Predict Surgical Outcomes for Kids with CP

Many children who undergo surgeries to improve mobility do not see significant gains.

• By Laurie Watanabe
• May 13, 2016

Research: Pediatric Support Surfaces Must Be Adjustable & Adaptable

Study was conducted by Amit Gefen of Tel Aviv University and Kara Kopplin of ROHO Inc.

• By Laurie Watanabe
• May 05, 2016

Report: Orphan Drug Appears to Slow ALS Progression

Masitinib is already approved for veterinary use in the United States.

• By Laurie Watanabe
• Apr 14, 2016

APTA CSM: Poster Presentation

CVA Therapy Referrals Driven by Patient Reports

• By Laurie Watanabe
• Apr 01, 2016

Study: Blood Loss with SCI Leads to Poorer Outcomes

Hemorrhaging after SCI can cause oxygen deprivation to injured areas.

• By Laurie Watanabe
• Mar 31, 2016

United Spinal Seeks Volunteers for UTI Study

New research study will examine lactobacillus impact on bladder health.

• By Laurie Watanabe
• Mar 22, 2016

Pharmaceutical Company to Continue Friedreich’s Ataxia Clinical Trial

RT001 drug was previously found to have no significant adverse effects.

• By Laurie Watanabe
• Feb 26, 2016

Researchers: Copper Treatments Stopped ALS Progression in Mice

Research teams are working toward expanding to human trials.

• By Laurie Watanabe
• Feb 04, 2016

Deep Tissue Injury Research, Part IV

How Clients Change & What We've Learned

• By Laurie Watanabe
• Feb 01, 2016

Transverse Myelitis Study Seeks Pediatric Participants

• Jan 01, 2016